Redefining Antimicrobial Drug DiscoveryThrough Host–Microbe Interactions

AntiBioX^® is a newly established EU-based nonprofit biotechnology initiative.

Our microbial interaction R&D platforms aim to uncover unprecedented antibiotics and antifungals.

Petri dish showing antimicrobial inhibition zone

The Antimicrobial Resistance (AMR) Crisis

The World Is Running Out of Effective Antibiotics
Antifungal drug resistance is also a growing concern
Antibiotic drug development pipelines are shrinking
A radical rethinking of antimicrobial discovery is needed, yet early-stage innovation remains critically underfunded

Drug-resistant bacteria

Antimicrobial pills and capsules

Empty research laboratory

The World Is Running Out of Effective Antibiotics

Drug-resistant bacteria

Antifungal drug resistance is also a growing concern

Antimicrobial pills and capsules

Antibiotic drug development pipelines are shrinking

Empty research laboratory

A radical rethinking of antimicrobial discovery is needed, yet early-stage innovation remains critically underfunded

Our Interdisciplinary Discovery Platforms

(Meta)Fungi-Derived Cryptic Antibiotics

Antibiosis by Hacking the Bacterial Cell Cycle

The Fungal Microbiome—Isolation of Bacteria Living Associated with Pathogenic Fungi to Identify New Antifungal Compounds.

Organizational Structure & Team

Core Team

EU-based Organizational Structure

Institutional & Individual Collaborators

Partnering

AntiBioX^® is built for scientific collaboration. We welcome:

Collaborations for applied research
Screening partnerships
Co-development of novel technologies

AntiBioX network

Sponsoring the Discovery

As a nonprofit, AntiBioX^® welcomes support through:

R&D Sponsorship — Invest in pathogen-specific discovery projects or help sustain our core operations.
Equipment Donations — We welcome apparatus for microbiology or chemistry R&D (including used lab equipment) to expand our screening capacity.

Celso Almeida, PhD, Director

almeida@antibiox.com

AntiBioX network